Pharmacists in Portland, Oregon
1293 Pharmacists found in Portland
Marie Jessica Waletich Flemming, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
503-494-8007
Ms. Marilani Su Ching, RPH
Pharmacist - Pharmacotherapy
1015 Nw 22nd Avenue, Pharmacy Services, Portland, OR 97210
503-412-7204
Dr. Mark William Cook Jr., PHARMD
Pharmacist
1123 N Hayden Meadows Dr, Portland, OR 97217
503-205-6661 503-205-8849
Dr. Mark Charles Sauer, PHARM.D.
Pharmacist
3710 Sw Us Veterans Hospital Rd, Portland, OR 97239
503-220-8262
Dr. Mark A Della Paolera, PHARMD, BCPS
Pharmacist - Pharmacotherapy
2400 Sw Vermont St, Portland, OR 97219
503-452-0915 503-892-9875
Dr. Markisha Marie White, PHARMD, RPH
Pharmacist
8330 N Ivanhoe St, Portland, OR 97203
503-205-1600 503-205-1604
Dr. Marlon Joseph Broussard, PHARM D
Pharmacist
501 N Graham St, Portland, OR 97227
503-413-4225 503-413-4515
Dr. Marta Brown, PHARMD
Pharmacist - Pharmacotherapy
3710 Sw Us Veterans Hospital Rd, P2phar, Portland, OR 97239
503-220-8262 503-721-7481
Martin M. K. Wong, PHARM D.
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
5717 Ne 138th Ave, Portland, OR 97230
888-807-5759
Dr. Martina Alexander Akeson, PHARMD
Pharmacist
6348 Ne Halsey St, Suite A, Portland, OR 97213
503-962-1700
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.